monarchE: Abemaciclib Reigns on in High-Risk Breast Cancer monarchE: Abemaciclib Reigns on in High-Risk Breast Cancer

Extended follow-up from monarchE shows ongoing event-free survival benefits with abemaciclib + endocrine therapy in high-risk early breast cancer, although even longer follow-up is required, say experts.Medscape Medical News
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news